Factors related to rapid progression of non‐small cell lung cancer in Chinese patients treated using single‐agent immune checkpoint inhibitor treatment

BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of non‐small cell lung cancer (NSCLC). While rapid progression (RP) has been proposed as a non‐negligible pattern of response to ICIs, its definition and related factors remain unclear. This study aimed to develop a cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Liang, Bai, Lianwei, Liu, Xianhong, Liu, Ying, Li, Shuang, Liu, Jingjing, Zhang, Shuang, Yang, Changliang, Ren, Xiubao, Cheng, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180579/
https://www.ncbi.nlm.nih.gov/pubmed/32134200
http://dx.doi.org/10.1111/1759-7714.13370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180579/
https://www.ncbi.nlm.nih.gov/pubmed/32134200
http://dx.doi.org/10.1111/1759-7714.13370

Ejemplares similares